Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1991;69(2):221–227.

Lack of efficacy of the standard potency Edmonston-Zagreb live, attenuated measles vaccine in African infants.

P Kiepiela 1, H M Coovadia 1, W E Loening 1, P Coward 1, G Botha 1, J Hugo 1, P J Becker 1
PMCID: PMC2393089  PMID: 1860150

Abstract

The efficacy of standard potency Edmonston-Zagreb (E-Z) measles vaccine was tested in a randomized trial of Black infants in a rural area of South Africa where a measles epidemic was occurring. The following immunization schedules were used: 48 infants aged 4-8.5 months who received 3.9 log 50 infectious units of E-Z vaccine (group A); 48 infants aged 4-8.5 months who received 3.28 log 50 infectious units of Schwarz vaccine (group B); and 28 infants aged greater than 9 months who received 3.28 log 50 infectious units of Schwarz vaccine and served as controls (group C). For infants aged less than 23 weeks who were given either the E-Z or Schwarz vaccine, the number of seropositives was low (28%), irrespective of the pre-vaccination level of measles antibody. There was a higher number of seropositives (68%) among those in the age range greater than 23 weeks to less than 36 weeks who received the E-Z vaccine rather than the Schwarz vaccine (36%). When administered to children aged greater than 36 weeks, the Schwarz vaccine produced a satisfactory, though suboptimal response rate (61%). There was no correlation between seropositivity and pre-vaccination measles antibody status. Use of the standard dose of E-Z vaccine may have been one of the factors for this poor response, and this supports the WHO recommendation that titres higher than the standard potency vaccine are needed if 6-month-old infants are to be successfully immunized against measles.

Full text

PDF
221

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaby P., Jensen T. G., Hansen H. L., Kristiansen H., Thårup J., Poulsen A., Sodemann M., Jakobsen M., Knudsen K., Clotilde da Silva M. Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy. Lancet. 1988 Oct 8;2(8615):809–811. doi: 10.1016/s0140-6736(88)92780-8. [DOI] [PubMed] [Google Scholar]
  2. Aaby P., Pedersen I. R., Knudsen K., da Silva M. C., Mordhorst C. H., Helm-Petersen N. C., Hansen B. S., Thårup J., Poulsen A., Sodemann M. Child mortality related to seroconversion or lack of seroconversion after measles vaccination. Pediatr Infect Dis J. 1989 Apr;8(4):197–200. [PubMed] [Google Scholar]
  3. Beck M., Smerdel S., Dedić I., Delimar N., Rajninger-Miholic M., Juzbasić M., Manhalter T., Vlatković R., Borcić B., Mihajić Z. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine. Dev Biol Stand. 1986;65:95–100. [PubMed] [Google Scholar]
  4. Black F. L., Berman L. L., Borgoño J. M., Capper R. A., Carvalho A. A., Collins C., Glover O., Hijazi Z., Jacobson D. L., Lee Y. L. Geographic variation in infant loss of maternal measles antibody and in prevalence of rubella antibody. Am J Epidemiol. 1986 Sep;124(3):442–452. doi: 10.1093/oxfordjournals.aje.a114415. [DOI] [PubMed] [Google Scholar]
  5. Black F. L., Berman L. L., Libel M., Reichelt C. A., Pinheiro F. D., Travassos da Rosa A., Figueira F., Siqueira Gonzales E. Inadequate immunity to measles in children vaccinated at an early age: effect of revaccination. Bull World Health Organ. 1984;62(2):315–319. [PMC free article] [PubMed] [Google Scholar]
  6. Black F. L. The role of herd immunity in control of measles. Yale J Biol Med. 1982 May-Aug;55(3-4):351–360. [PMC free article] [PubMed] [Google Scholar]
  7. Khanum S., Uddin N., Garelick H., Mann G., Tomkins A. Comparison of Edmonston-Zagreb and Schwarz strains of measles vaccine given by aerosol or subcutaneous injection. Lancet. 1987 Jan 17;1(8525):150–153. doi: 10.1016/s0140-6736(87)91978-7. [DOI] [PubMed] [Google Scholar]
  8. Kiepiela P., Coovadia H. M., Coward P., Woodhead R., Abdool-Karim S. S., Becker P. Age-related lymphocyte sub-population changes among healthy Africans from birth to adulthood. Ann Trop Paediatr. 1989 Dec;9(4):199–205. doi: 10.1080/02724936.1989.11748633. [DOI] [PubMed] [Google Scholar]
  9. Loening W. E., Coovadia H. M. Age-specific occurrence rates of measles in urban, peri-urban, and rural environments: implications for time of vaccination. Lancet. 1983 Aug 6;2(8345):324–326. doi: 10.1016/s0140-6736(83)90299-4. [DOI] [PubMed] [Google Scholar]
  10. Sabin A. B., Flores Arechiga A., Fernández de Castro J., Albrecht P., Sever J. L., Shekarchi I. Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response. JAMA. 1984 May 11;251(18):2363–2371. [PubMed] [Google Scholar]
  11. Sabin A. B., Flores Arechiga A., Fernández de Castro J., Sever J. L., Madden D. L., Shekarchi I., Albrecht P. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines. JAMA. 1983 May 20;249(19):2651–2662. [PubMed] [Google Scholar]
  12. Sabin A. B. Immunization against measles by aerosol. Rev Infect Dis. 1983 May-Jun;5(3):514–523. doi: 10.1093/clinids/5.3.514. [DOI] [PubMed] [Google Scholar]
  13. Wesley A., Coovadia H. M., Watson A. R. Immunization against measles in children at risk for severe disease. Trans R Soc Trop Med Hyg. 1979;73(6):710–715. doi: 10.1016/0035-9203(79)90026-9. [DOI] [PubMed] [Google Scholar]
  14. Whittle H. C., Mann G., Eccles M., O'Neill K., Jupp L., Hanlon P., Hanlon L., Marsh V. Effects of dose and strain of vaccine on success of measles vaccination of infants aged 4-5 months. Lancet. 1988 Apr 30;1(8592):963–966. doi: 10.1016/s0140-6736(88)91780-1. [DOI] [PubMed] [Google Scholar]
  15. Whittle H. C., Rowland M. G., Mann G. F., Lamb W. H., Lewis R. A. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine. Lancet. 1984 Oct 13;2(8407):834–837. doi: 10.1016/s0140-6736(84)90873-0. [DOI] [PubMed] [Google Scholar]
  16. Whittle H., Hanlon P., O'Neill K., Hanlon L., Marsh V., Jupp E., Aaby P. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects. Lancet. 1988 Oct 8;2(8615):811–814. doi: 10.1016/s0140-6736(88)92781-x. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES